BY OUR PLATFORMS
BY THERAPEUTIC AREA
BY SECTOR
Ana G. Duran - 30 April 2024
Readily assess visual function in a live organism
Miriam Martínez - 19 March 2024
Harness the potential of our new Zebrafish-Based Platform for High-Throughput Gene Target Validation and Drug Screening in F0
Valentina Schiavone - 26 April 2023
The United States approves technological alternatives to reduce animal testing
Miriam Martínez - 13 October 2022
Zebrafish contribution to drug development reaching clinical stages
Javier Terriente - 15 September 2022
AI can address many challenges and limitations in traditional R&D and offer value in drug discovery in multiple ways.
Carles Cornet - 11 May 2022
Why zebrafish can pave the way for investigating epilepsy’s etiology and screening new anti-seizure drugs
Miriam Martínez - 16 March 2022
How to choose which type of experiment is best-suited for my research?
Vincenzo Di Donato - 24 November 2021
Leveraging zebrafish to study Age-related Macular Degeneration
Christian Cortés - 20 September 2021
The emerging use of zebrafish to model metabolic diseases
Miriam Martínez - 21 July 2021
Are zebrafish suitable for human drug discovery?
Vincenzo Di Donato - 13 January 2021
ZeClinics laboratory R&D efforts are mainly divided in the development of three research platforms including a number of research areas.